Press release
Global Dysmenorrhea Treatment Market to reach USD 7,909.14 million by 2032 at a CAGR of 6.88% by 2032, Evaluates DelveInsight
DelveInsight's "Dysmenorrhea Treatment Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Dysmenorrhea Treatment companies actively working in the market.
To know more about why North America is leading the market growth in the Dysmenorrhea Treatment market, get a snapshot of the report Dysmenorrhea Treatment Market Trends
https://www.delveinsight.com/sample-request/dysmenorrhea-treatment-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Dysmenorrhea Treatment Overview
Dysmenorrhea treatment refers to the medical and therapeutic approaches used to manage menstrual pain or cramps experienced before or during menstration. Treatment options vary based on the severity and cause of the condition and may include over-the-counter pain relievers (such as NSAIDs), hormonal therapies like oral contraceptives, lifestyle changes (exercise, heat therapy, diet), and in some cases, prescription medications or surgical interventions for underlying issues such as endometriosis or fibroids. The goal of treatment is to reduce pain, improve quality of life, and address any underlying reproductive health conditions contributing to the discomfort.
DelveInsight Analysis: The dysmenorrhea treatment market size was valued at USD 4,693.08 million in 2024 and is expected to grow at a CAGR of 6.88% from 2025 to 2032, reaching an estimated USD 7,909.14 million by 2032.
Dysmenorrhea Treatment Market Insights
Geographically, North America is expected to dominate the dysmenorrhea treatment market in 2024, supported by several major factors. The region benefits from a well-developed healthcare system, strong awareness of menstrual health issues, and a growing preference for advanced treatment solutions. There has been a notable rise in the use of non-invasive, drug-free options such as TENS devices, heat-based therapies, and wearable pain relief technologies. In addition, increased emphasis on women's health, favorable regulatory policies, and expanding R&D efforts aimed at developing innovative menstrual pain management products are further driving market growth in the region.
To read more about the latest highlights related to Dysmenorrhea Treatment, get a snapshot of the key highlights entailed in the Dysmenorrhea Treatment Insights
https://www.delveinsight.com/report-store/dysmenorrhea-treatment-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Dysmenorrhea Treatment Market Report
• In September 2024, Organon K.K., a global healthcare company focused on women's health, announced that it had achieved the primary endpoint in a domestic Phase III clinical trial evaluating the efficacy and safety of OG-8276A for dysmenorrhea. Based on the trial results, the company prepared to apply for marketing approval and launch in Japan.
• In October 2023, Fuji Pharma Co., Ltd. and M3, Inc. announced that Fuji had applied for marketing approval of the estetrol/drospirenone combination product (Development code: FSN-013), co-developed in Japan, to the Ministry of Health, Labour and Welfare (MHLW) for the scheduled indication of dysmenorrhea.
• Thus, owing to such developments in the market, rapid growth will be observed in the Dysmenorrhea Treatment market during the forecast period
Key Players in the Dysmenorrhea Treatment Market
Some of the key market players operating in the Dysmenorrhea Treatment market include- Johnson & Johnson Services Inc., iPulse Medical Ltd., Bridges CHC, LLC., AbbVie Inc., Myoovi Ltd., Rael Inc., Abbott, Pfizer Inc., TensCare Ltd. (UK), Beurer GmbH (Germany), BPL Medical Technologies, Cora, Carex Health Brands (USA), Sumitovant Biopharma, Emcure Pharmaceuticals, Everteen, Samphire Neuroscience, Mirapulse, Welme, Nomisk, and others.
Which MedTech key players in the Dysmenorrhea Treatment market are set to emerge as the trendsetter explore @ Key Dysmenorrhea Treatment Companies
https://www.delveinsight.com/sample-request/dysmenorrhea-treatment-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the Dysmenorrhea Treatment Market Landscape
The ease of at-home use and quick pain relief make these solutions especially attractive for women with busy schedules or those who prefer to avoid long-term medication. Innovations in wearable devices, smartphone connectivity, and user-friendly designs have also enhanced comfort and adherence. A notable example is MIMA 2.0, a compact, portable, IoT-enabled menstrual device that offers features such as leak resistance, antibacterial and anti-odor materials, and a Bluetooth-controlled heating system for cramp relief. By addressing multiple symptoms in one product, it reflects the growing demand for integrated, tech-driven menstrual health solutions.
Together, these factors are expected to significantly strengthen this segment, contributing to the overall growth of the dysmenorrhea treatment market throughout the 2025-2032 forecast period.
Scope of the Dysmenorrhea Treatment Market Report
• Coverage: Global
• Study Period: 2022-2032
• Dysmenorrhea Treatment Market Segmentation By Type: Primary Dysmenorrhea and Secondary Dysmenorrhea
• Dysmenorrhea Treatment Market Segmentation By Treatment: Drugs, Devices, and Others
• Dysmenorrhea Treatment Market Segmentation By End-User: Hospitals, Gynecology & Wellness Clinics, and Homecare Settings
• Dysmenorrhea Treatment Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Dysmenorrhea Treatment Companies: Johnson & Johnson Services Inc., iPulse Medical Ltd., Bridges CHC, LLC., AbbVie Inc., Myoovi Ltd., Rael Inc., Abbott, Pfizer Inc., TensCare Ltd. (UK), Beurer GmbH (Germany), BPL Medical Technologies, Cora, Carex Health Brands (USA), Sumitovant Biopharma, Emcure Pharmaceuticals, Everteen, Samphire Neuroscience, Mirapulse, Welme, Nomisk, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the Dysmenorrhea Treatment market will grow by 2032? Click to get a snapshot of the Dysmenorrhea Treatment Market Analysis
https://www.delveinsight.com/sample-request/dysmenorrhea-treatment-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Dysmenorrhea Treatment Market to reach USD 7,909.14 million by 2032 at a CAGR of 6.88% by 2032, Evaluates DelveInsight here
News-ID: 4255722 • Views: …
More Releases from DelveInsight Business Research
Global Clinical Trial Support Services Market to reach USD 43,160.56 million by …
According to DelveInsight's analysis, The clinical trial support services market is expanding swiftly, largely driven by the increasing incidence of chronic illnesses such as diabetes, cancer, and cardiovascular diseases. This rise has resulted in a higher volume of clinical trials, greater R&D spending, and stronger investment in new drug development. Moreover, the growing collaboration among pharmaceutical, biotechnology, and medical device companies is boosting the need for specialized services, including regulatory…
Global Respiratory Inhalers Market to reach USD 51,132.25 million by 2032 at a C …
According to DelveInsight's analysis, The demand for respiratory inhalers is rising sharply, driven by a combination of factors. Chief among these is the increasing prevalence of respiratory disorders, including asthma, COPD, bronchitis, and bronchospasm, which continue to impact a growing global population and create a need for fast and effective treatments. Simultaneously, patient awareness regarding early diagnosis and consistent management of asthma and COPD is improving, further supporting market growth.…
Global Thrombectomy Devices Market to reach USD 2,806.85 million by 2032 at a CA …
According to DelveInsight's analysis, The increasing demand for thrombectomy devices is being propelled by several key factors contributing to robust market growth. The global rise in neurological and cardiovascular conditions such as acute ischemic stroke, pulmonary embolism, and deep vein thrombosis creates a critical need for timely and effective interventions. There is also a growing preference among patients and healthcare providers for minimally invasive treatment options. Additionally, ongoing innovations and…
UCB's KYGEVVI FDA Approval: Unprecedented Milestone in Thymidine Kinase 2 Defici …
The FDA approval of KYGEVVI (doxecitine and doxribtimine) on November 3, 2025, fundamentally reshaped the thymidine kinase 2 deficiency (TK2d) treatment landscape. This first-and-only approved therapy for TK2d marks an unprecedented shift in the thymidine kinase 2 deficiency treatment market, which is expected to grow at a CAGR of 50% from a USD 5 million valuation in 2025.
Understanding the Disease and Unmet Medical Need
Thymidine kinase 2 deficiency is an ultra-rare,…
More Releases for Dysmenorrhea
Dysmenorrhea Market Share, Epidemiology, Analysis & Trends 2023-2033
Market Overview:
The dysmenorrhea market is expected to exhibit a CAGR of 5.67% during 2023-2033. The dysmenorrhea market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the market share of various therapies, and the market's performance in the seven major…
Dysmenorrhea - Drug Pipeline Landscape, 2022
Global Dysmenorrhea Market report from Global Insight Services is the single authoritative source of intelligence on Dysmenorrhea market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and…
Dysmenorrhea - Drug Pipeline Landscape, 2022
Dysmenorrhea, also known as painful periods or menstrual cramps, is a common problem experienced by women during their reproductive years. It is estimated that 50-90% of women of reproductive age suffer from dysmenorrhea. The pain is usually felt in the lower abdomen and can range from mild to severe. The pain may begin one to two days before the start of menstru*tion and last for the first few days of…
Dysmenorrhea - Drug Pipeline Landscape, 2022
Dysmenorrhea, also known as painful periods or menstrual cramps, is a common problem experienced by women during their reproductive years. It is estimated that 50-90% of women of reproductive age suffer from dysmenorrhea. The pain is usually felt in the lower abdomen and can range from mild to severe. The pain may begin one to two days before the start of and last for the first few days of…
Dysmenorrhea Treatment Market: Market Intelligence and Market Trends
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause…
Dysmenorrhea Treatment Market size and forecast, 2016-2026
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause…
